Chaotic, Disorganized, and Mismanaged - Scientist Zymeworks Employee Review

1.0
May 27, 2022
Recommend
CEO approval
Business outlook

Pros

Zanidatamab is an excellent asset

Cons

- Talented & experienced group of scientists that developed Zanidatamab are no longer at Zymeworks - Senior Scientific leadership does not have the necessary drug development experience - Success of pipeline projects doesn't matter, company is treading water to get to a sale - CEO has no history developing medicine or building companies. His history is dominated by breaking apart and selling assets. - Former CFO, at least partly responsible for the cratering of the company, is allowed to remain and transition to COO. - Company still talks about its values as though they determine corporate behavior

Explore other reviews about Zymeworks

5.0
Jan 15, 2025
Recommend
CEO approval
Business outlook

Pros

Good discipline nice work experience

Cons

No bad experience it was good

4.0
Apr 10, 2026
Recommend
CEO approval
Business outlook

Pros

Good mangement okay salary good

Cons

Nothing to say from me

See reviews by: Helpful|Rating|Date|All